Compare Lustrum:Renascience Inc.:4889

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Renascience Inc. Go to web site 4889 Medicals 東証グロース March 1, 2000 2021.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Renascience Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Balance Sheet 2025年3月期 Renascience Inc. Balance Sheet 2024年3月期 Renascience Inc. Balance Sheet 2023年3月期 Renascience Inc. Balance Sheet 2022年3月期 Renascience Inc. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents
(Percent)
1,800down
(96.2%)down
2,027down
(97.0%)down
2,212down
(97.3%)down
2,387up
(97.9%)up
1,026
(96.2%)
Other Current AssetsHelp
(Percent)
71up
(3.8%)up
60up
(2.9%)up
55up
(2.4%)up
42up
(1.7%)up
17
(1.6%)
Tangible Fixed AssetsHelp
(Percent)

-
0
-
4up
(0.2%)up
4up
(0.1%)down
4
(0.3%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
(0.0%)
0
-
13
(1.2%)
Investments and OthersHelp
(Percent)
0down
(0.0%)down
2down
(0.1%)down
3down
(0.1%)down
6down
(0.3%)down
7
(0.7%)
Total AssetsHelp
(Percent)
1,871
(100%)
2,089
(100%)
2,275
(100%)
2,438
(100%)
1,067
(100%)
Total Current LiabilitiesHelp
(Percent)
151up
(8.1%)up
126up
(6.0%)up
100up
(4.4%)up
38up
(1.6%)down
29
(2.8%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
356up
(17.0%)up
310up
(13.6%)up
199down
(8.2%)down
476
(44.6%)
Shareholder's EquityHelp
(Percent)
1,720up
(91.9%)up
1,607down
(76.9%)down
1,865down
(82.0%)down
2,201up
(90.3%)up
562
(52.6%)
Total LiabilitiesHelp
(Percent)
1,871
(100%)
2,089
(100%)
2,275
(100%)
2,438
(100%)
1,067
(100%)

Renascience Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Profit and Loss Account 2025年3月期 Renascience Inc. Profit and Loss Account 2024年3月期 Renascience Inc. Profit and Loss Account 2023年3月期 Renascience Inc. Profit and Loss Account 2022年3月期 Renascience Inc. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales
(Percent)
133
(100%)
194
(100%)
101
(100%)
139
(100%)
210
(100%)
Total Sales
(Percent)
133
(100%)
194
(100%)
101
(100%)
139
(100%)
210
(100%)
Cost of SalesHelp
(Percent)
4down
(2.8%)down
29up
(14.7%)up
0down
(0.2%)down
58up
(41.9%)up
30
(14.3%)
Other Costs and RevenueHelp 16down
(11.7%)down
424down
(218.4%)down
436up
(433.7%)up
335up
(240.6%)up
280
(133.4%)
Total CostsHelp 19 452 436 394 310
Net RevenueHelp 129down
(97.2%)up
166up
(85.3%)down
100up
(99.8%)up
81down
(58.1%)down
180
(85.7%)
Earnings Before TaxHelp 144up
(108.3%)up
-256up
(-132.0%)up
-334down
(-332.0%)down
-253down
(-181.6%)down
-100
(-47.5%)
Net IncomeHelp 113up
(85.5%)up
-258up
(-133.0%)up
-336down
(-334.0%)down
-254down
(-182.5%)down
-100
(-47.7%)
当期純利益 113 -258 -336 -254 -100

Renascience Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Renascience Inc. Cash Flow Statement 2025年3月期 Renascience Inc. Cash Flow Statement 2024年3月期 Renascience Inc. Cash Flow Statement 2023年3月期 Renascience Inc. Cash Flow Statement 2022年3月期 Renascience Inc. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help
(Percent)
-176up
(-46.1%)up
-231up
(-99.3%)up
-285down
(-100.0%)down
-230down
(-14.5%)up
-89
(-65.8%)
Investing Cash Flow(ICF)Help
(Percent)
382up
(100.0%)up
-2down
(-0.7%)down
0up
(0.1%)up
-0up
(0.0%)up
-2
(-1.3%)
Financing Cash FlowHelp
(Percent)
-52down
(-13.7%)down
47down
(20.0%)down
110down
(38.8%)down
1,592up
(100.0%)
136
(100.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0up
(0.0%)up
-0down
(0.0%)down
0
(0.0%)
0
-
-0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn 154up
(40.2%)up
-186down
(-80.0%)down
-174down
(-61.1%)down
1,361up
(85.5%)up
45
(32.9%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Renascience Inc.

Company where related level is highHelp

Kubota Pharmaceutical Holdings Co.,Ltd.
Carna Biosciences,Inc.
K Pharma,Inc.
SANTEN PHARMACEUTICAL CO.,LTD.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
MIKASA SEIYAKU CO.,LTD.
ONO PHARMACEUTICAL CO.,LTD.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
Kyowa Kirin Co.,Ltd.
DENKA SEIKEN Co.,Ltd.